Ralaniten (Standard)
Ralaniten (Standard) is the analytical standard of Ralaniten (HY-109070). This product is intended for research and analytical applications. Ralaniten (EPI-002) is a potent and orally active antagonist of the androgen receptor-N-terminal domain (AR-NTD). Ralaniten inhibits AR transcriptional activity, with IC50 of 7.4 μM. Ralaniten can be used for the research of castration-resistant prostate cancer (CRPC).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1203490-23-6
- Formel: C21H27ClO5
- Molecular Weight:394.89
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Reinheit & Dokumentation
-
Help & FAQs
-
HY-138641
Bavdegalutamide -
HY-135794
11-Ketodihydrotestosterone -
HY-N0790
Lupeol -
HY-N1943
Ailanthone -
HY-15194
Dimethylcurcumin -
HY-N0790R
Lupeol (Standard) -
HY-111024
2,2,5,7,8-Pentamethyl-6-Chromanol -
HY-136582
Masofaniten -
HY-137448
Rezvilutamide -
HY-N0475
Triptophenolide -
HY-70002A
N-Desmethyl enzalutamide -
HY-B1405
Dehydroisoandrosterone 3-acetate
Product Information
Information
Anwendung
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS. Nr. 1203490-23-6
-
Molecular Weight 394.89
-
Formel C21H27ClO5
-
SMILES
CC(C1=CC=C(OC[C@H](O)CCl)C=C1)(C2=CC=C(OC[C@H](O)CO)C=C2)C
-
Synonyms
EPI-002 (Standard)
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Myung JK, et, al. An androgen receptor N-terminal domain antagonist for treating prostate cancer. J Clin Invest. 2013 Jul;123(7):2948-60. [Content Brief]
[2]. Yang YC, et, al. Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer. Clin Cancer Res. 2016 Sep 1;22(17):4466-77. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Ralaniten (Standard) Related Classifications
HY-109070R Related Classifications
Powered by Bioz